An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers

计划入组 24 人 · 首次发布于 2020 年 5 月 13 日

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

Hepapoietin(Daiichi Sankyo Co., Ltd.)

Budralazine(Daiichi Sankyo Co., Ltd.)

Glucagon-like peptide 1 7-36 amide(Daiichi Sankyo Co., Ltd.)

Daiichi Sankyo Co., Ltd.

Japan

DAIICHI SANKYO HEALTHCARE CO., LTD.

Japan

Daiichi Sankyo Pharmaceutical(Shanghai) Co.,Ltd

China

Tenosynovial Giant Cell Tumors Treatment Market to See Significant Growth by 2034

Global Stroke Clinical Trials Landscape Analysis Reveals Key Market Trends for 2025

Syros' Tamibarotene Fails Phase III Trial in MDS Patients